Stockreport

CRSP's Q3 Loss Narrower Than Expected, Sales Miss Estimates [Yahoo! Finance]

CRISPR Therapeutics AG - Common Shares  (CRSP) 
Last crispr therapeutics ag - common shares earnings: 8/7 05:01 pm Check Earnings Report
US:NASDAQ Investor Relations: nasdaq.com/symbol/crsp/real-time
PDF In the year-ago period, the company incurred a loss of $1.41 per share. Total revenues, though negligible, were entirely from grant revenues, which amounted to $0.6 mi [Read more]